Table 2.
Genotype frequencies of Hsp70-hom in control subjects and in patients with Kangri cancer
| Genotype | Kangri cancer (n=118) (f) | Control (n=95) (f) | Odd's ratio; χ2P |
|---|---|---|---|
| Hsp70-2 C/C | (60)0.51 | (28)0.29 | 2.47(95% CI= 1.43-4.30); χ2P< 0.05 |
| Hsp70-2 C/G | (56)0.47 | (60)0.63 | 0.526(95% CI= 0.30-0.91); χ2P< 0.05 |
| Hsp70-2 G/G | (2)0.02 | (7)0.08 | $NS; χ2=12.21, P = 0.002 |
| Allele | Allele frequency | ||
| C | 0.74 | 0.61 | 1.87(95% CI= 1.23-2.82); χ2P< 0.05 |
| G | 0.26 | 0.39 | 0.53(95% CI= 0.35-0.80); χ2P< 0.05 |
Hsp= Heat shock protein; f = genotypefrequencies; χ2 = Chi-square; OR= odds ratio;
$
NS= Not significant; The Chi-square test was used whether significant differences (P-value) in genotype frequencies were observed when patient group was compared with control subjects